Research Paper Volume 16, Issue 9 pp 8171—8197
Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma
Figure 5. The prognosis of HCC subtypes with LRRC59 overexpression is poor. (A–C) The TCGA-LIHC dataset was clustered and subtyped, and the relationship between LRRC59 expression and prognosis in each subtype was analyzed. (D–F) The ICGC-LIRI dataset was clustered and subtyped, and the relationship between LRRC59 expression and prognosis in each subtype was analyzed. (G, H) Visualization of clinical characteristics of each HCC subtype. (I, J) Clinical enrichment analysis of mutations in each HCC subtypes.